Cetera Investment Advisers
GH icon

Cetera Investment Advisers’s Guardant Health GH Stock Holding History

Cetera Investment Advisers’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.45M Sell
9,638
-2,490
-21% -$271K ﹤0.01% 2681
2026
Q1 		$1.12M Buy
12,128
+3,363
+38% +$338K ﹤0.01% 2808
2025
Q4 		$895K Sell
8,765
-246
-3% -$22K ﹤0.01% 2913
2025
Q3 		$563K Buy
9,011
+4,029
+81% +$219K ﹤0.01% 3283
2025
Q2 		$259K Buy
4,982
+21
+0.4% +$938 ﹤0.01% 3518
2025
Q1 		$211K Buy
+4,961
New +$214K ﹤0.01% 3560
2021
Q4 		– Sell
-1,768
Closed -$221K – 1895
2021
Q3 		$221K Sell
1,768
-745
-30% -$88.5K ﹤0.01% 1607
2021
Q2 		$312K Buy
2,513
+402
+19% +$54.1K 0.01% 1390
2021
Q1 		$322K Sell
2,111
-3,415
-62% -$516K 0.01% 1222
2020
Q4 		$712K Buy
+5,526
New +$636K 0.01% 803
2019
Q3 		– Sell
-2,400
Closed -$206K – 552
2019
Q2 		$206K Buy
+2,400
New +$183K 0.03% 485

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Cetera Investment Advisers's GH Position: Q2 2026 in Review

Cetera Investment Advisers reduced its Guardant Health (GH) stake by 21% in Q2 2026, selling an estimated $271K and leaving 9,638 shares worth $1.45M. The position accounts for ﹤0.01% of the portfolio, ranked #2681.

Cetera Investment Advisers first reported a position in GH in Q2 2019 and has held it in 11 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Cetera Investment Advisers held 9,638 shares of Guardant Health worth $1.45M as of Q2 2026.
  • Cetera Investment Advisers sold 2,490 Guardant Health shares in Q2 2026, an estimated $271K.
  • Guardant Health made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #2681 holding.
  • Cetera Investment Advisers first reported a position in Guardant Health in Q2 2019 and has held it in 11 quarters since.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.